BCR-ABL1 kinase domain mutation screening using next generation sequencing in CML and Ph plus ALL patients
Egile Nagusiak: | , , , , , , , , , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
Wiley
2019
|
Egile Nagusiak: | , , , , , , , , , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
Wiley
2019
|